Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
6
Mins
22 Nov 2018
Positive Phase II Trial Results Assessing Ustekinumab for the Treatment of Systemic Lupus Erythematosus (SLE)
Lupus is a condition for which the creation of new treatment options is of paramount importance. There is as yet no cure for the disease…
9
Mins
13 Oct 2018
Effect of Mesenchymal Stem Cells in Autoimmune Arthritis
The most common autoimmune diseases that affect the joints are osteoarthritis (OA) and rheumatoid arthritis (RA). The pathogeneses of both OA and RA are…
10
Mins
4 Sep 2018
Switching from Reference to Biosimilar Products: An Overview of the European Approach and Real-World Experience So Far
Switching patients from a reference to a biosimilar product has become a primary topic of interest, with different approaches being undertaken by the…
9
Mins
4 Sep 2018
Knee Infection After Anterior Cruciate Ligament Reconstruction
This article presents a case of infection after ACL reconstruction and discusses risk factors, treatment choice, antibiotic treatment length, and functional outcomes, proposing a guide for the treatment.
11
Mins
4 Sep 2018
The Role of Nicotinamide Adenine Dinucleotide in the Pathogenesis of Rheumatoid Arthritis: Potential Implications for Treatment
The aim of this review is to illustrate the role of NAD+-related enzymes in the pathogenesis of RA and highlight the potential therapeutic role of NAD+ in RA.
31 Aug 2018
TNF Inhibitor Treatment and Cancer Recurrence in Rheumatoid Arthritis
Cancer recurrence after TNF inhibitor (TNFi) treatment in rheumatoid arthritis (RA) patients with a history of solid cancer was no greater than in a…
31 Aug 2018
TNF Inhibitors and Cardiovascular Events
Reduced risk of cardiovascular events has been associated with sustained treatment with biologics or TNF inhibitors in patients with rheumatoid arthritis…
7 Aug 2018
Treatment for Rare Genetic Disease Provides Hope for Thousands
A treatment for the very rare genetic disease alkaptonuria (AKU) has been identified by a research collaboration involving the University of Liverpool…
Loading posts...
« Previous
1
…
61
62
63
64
65
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View